299 related articles for article (PubMed ID: 16858970)
21. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
Donghi R; Longoni A; Pilotti S; Michieli P; Della Porta G; Pierotti MA
J Clin Invest; 1993 Apr; 91(4):1753-60. PubMed ID: 8473515
[TBL] [Abstract][Full Text] [Related]
22. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S; Stephan M; Kögler G
Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
[TBL] [Abstract][Full Text] [Related]
23. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
Kim YW; Do IG; Park YK
Pathol Res Pract; 2006; 202(11):759-65. PubMed ID: 17029809
[TBL] [Abstract][Full Text] [Related]
24. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
25. [Poorly-differentiated thyroid carcinoma: morphological verification and differential diagnosis].
Friedman MV
Vopr Onkol; 2006; 52(1):47-53. PubMed ID: 16715703
[TBL] [Abstract][Full Text] [Related]
26. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?
Dettmer M; Schmitt A; Steinert H; Haldemann A; Meili A; Moch H; Komminoth P; Perren A
Am J Surg Pathol; 2011 Dec; 35(12):1866-72. PubMed ID: 21989341
[TBL] [Abstract][Full Text] [Related]
27. Unusual thyroid tumors: a review of pathologic and molecular diagnosis.
Hunt JL
Expert Rev Mol Diagn; 2005 Sep; 5(5):725-34. PubMed ID: 16149875
[TBL] [Abstract][Full Text] [Related]
28. Expression of nestin mRNA is a differentiation marker in thyroid tumors.
Yamada H; Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Watanabe M; Iwatani Y; Miyauchi A
Cancer Lett; 2009 Jul; 280(1):61-4. PubMed ID: 19268442
[TBL] [Abstract][Full Text] [Related]
29. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
[TBL] [Abstract][Full Text] [Related]
30. Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis.
Jung SJ; Chung JI; Park SH; Ayala AG; Ro JY
Am J Surg Pathol; 2006 Mar; 30(3):411-5. PubMed ID: 16538064
[TBL] [Abstract][Full Text] [Related]
31. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
32. S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma.
Ito Y; Arai K; Nozawa R; Yoshida H; Hirokawa M; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Anticancer Res; 2009 Oct; 29(10):4157-61. PubMed ID: 19846966
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
34. Frequency of medullary thyroid carcinoma in an endemic goiter area.
Schmid KW; Tötsch M; Hittmair A; Feichtinger H; Ladurner D; Hofstädter F
Mod Pathol; 1989 Mar; 2(2):90-3. PubMed ID: 2542931
[TBL] [Abstract][Full Text] [Related]
35. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
[TBL] [Abstract][Full Text] [Related]
36. Insular carcinoma of thyroid--a case report.
Jain R; Chaturvedi KU; Khurana N; Aggarwal AK
Indian J Pathol Microbiol; 2004 Jul; 47(3):420-2. PubMed ID: 16295445
[TBL] [Abstract][Full Text] [Related]
37. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Int J Mol Med; 2002 Apr; 9(4):373-6. PubMed ID: 11891530
[TBL] [Abstract][Full Text] [Related]
38. Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation.
Dann CT; Alvarado AL; Molyneux LA; Denard BS; Garbers DL; Porteus MH
Stem Cells; 2008 Nov; 26(11):2928-37. PubMed ID: 18719224
[TBL] [Abstract][Full Text] [Related]
39. Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study.
Basolo F; Pollina L; Pacini F; Fontanini G; Ménard S; Castronovo V; Bevilacqua G
Clin Cancer Res; 1996 Oct; 2(10):1777-80. PubMed ID: 9816129
[TBL] [Abstract][Full Text] [Related]
40. [C-cells in malignant epithelial tumors of the thyroid gland].
Derizhanova IS; Sidorenko SI
Vopr Onkol; 1998; 44(6):686-90. PubMed ID: 10087965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
